# Filing Detail

Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001437749-22-005763
Filing Date
2022-03-10
Accepted
2022-03-09 20:40:10
Documents
61

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | govx20220301_posam.htm | POS AM | 1182502
2 |  | ex_344151.htm | EX-23.1 | 2853
3 |  | virusstructure.jpg | GRAPHIC | 47749
4 |  | img01.jpg | GRAPHIC | 3332
5 |  | lrglogo.jpg | GRAPHIC | 14711
| Complete submission text file | 0001437749-22-005763.txt |  | 4391081

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 |  | govx-20211231.xml | EX-101.INS | 567237
7 |  | govx-20211231.xsd | EX-101.SCH | 49135
8 |  | govx-20211231_cal.xml | EX-101.CAL | 32683
9 |  | govx-20211231_def.xml | EX-101.DEF | 334147
10 |  | govx-20211231_lab.xml | EX-101.LAB | 290691
11 |  | govx-20211231_pre.xml | EX-101.PRE | 356208

Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-262541 | Film No.: 22727120
SIC: 2834 Pharmaceutical Preparations